Pediatric nephrotic syndrome (NS) is a significant glomerular disorder marked by heavy proteinuria, edema, hypoalbuminemia, and hyperlipidemia, predominantly affecting children aged 1-6 years. This paper reviews the current understanding of NS, emphasizing its pathophysiology, clinical presentation, diagnosis, and management strategies. Minimal Change Disease (MCD) is the leading cause, accounting for 70-90% of cases, with corticosteroids as the primary treatment, achieving remission in most cases. However, relapses and steroid resistance necessitate alternative therapies like calcineurin inhibitors and rituximab. Complications such as infections, thromboembolism, and growth retardation highlight the need for comprehensive care. Future perspectives include genetic testing, personalized medicine, and novel therapeutics to enhance outcomes and reduce steroid dependency. This review underscores the importance of ongoing research and global collaboration to refine treatment protocols and improve the quality of life for affected children.

nephrotic syndrome, pediatric, minimal change disease, corticosteroids, personalized medicine

Adhamjon o'g, A. A. Z., & Mo'minjonovna, M. B. (2025, May). CLINICAL PHARMACOLOGY OF ANTI-INFLAMMATORY DRUGS. In CONFERENCE OF MODERN SCIENCE & PEDAGOGY (Vol. 1, No. 2, pp. 88-91).

Amira Peco-Antic. Management of idiopathic nephrotic syndrome in childhood // Srpski Arhiv Za Celokupno Lekarstvo. 2004. Vol. 132. P. 352–359.

Anca Croitoru, Mihaela Balgradean. Treatment-Associated Side Effects in Patients with Steroid-Dependent Nephrotic Syndrome. 2022. Vol. 17 2, № 2. P. 285–290.

Anne Couderc et al. Traitements du syndrome néphrotique cortico-dépendant de l’enfant // Archives De Pediatrie. 2017. Vol. 24, № 12. P. 1312–1320.

Boboxonova, M. (2025). COMBATING EARLY MENOPAUSE: MODERN MEDICAL APPROACHES AND NATURAL TREATMENT METHODS. International Journal of Artificial Intelligence, 1(4), 56-59.

Federica Zotta, Marina Vivarelli, Francesco Emma. Update on the treatment of steroid-sensitive nephrotic syndrome // Pediatric Nephrology. 2021. P. 1–12.

Ganiyeva, M. R. (2024, December). CLINICAL AND MORPHOFUNCTIONAL CHANGES IN THE RETINA IN HIGH MYOPIA IN COMBINATION WITH AGE-RELATED MACULAR DEGENERATION OF DIFFERENT STAGES. In International Conference on Modern Science and Scientific Studies (pp. 141-142).

Ikromova, N. (2024). TABIIY SIANOGLIKOZID-AMIGDALINNING KIMYOVIY XOSSALARI VA AMALIY AHAMIYATI. Universal xalqaro ilmiy jurnal, 1(6), 26-29.

Ikromova, N. (2024, October). AMIGDALIN HOSILALARI SINTEZI ISTIQBOLLARI. In CONFERENCE ON THE ROLE AND IMPORTANCE OF SCIENCE IN THE MODERN WORLD (Vol. 1, No. 8, pp. 164-166).

Marina Vivarelli et al. Childhood nephrotic syndrome // The Lancet. 2023. Vol. 402. P. 809–824.

Mo’Minjonovna, B. M., & O’G’Li, M. A. R. (2024). STUDY AND ANALYSIS OF THE PHARMACOLOGICAL PROPERTIES OF MEDICINAL PLANTS, WHICH ARE CARDIAC GLYCOSIDES USED IN CLINICAL PRACTICE. Eurasian Journal of Medical and Natural Sciences, 4(1-1), 80-83.

Raqiboyevna, G. M., & Abdulhay, M. (2025). PREVENTION OF COMPLICATIONS OF CARDIOVASCULAR DISEASES BY ORGANIZING MORPHOLOGICAL AND CLINICAL INDICATORS OF ARCUS SENILIS. Modern education and development, 26(4), 201-204.

Raqiboyevna, G. M., & Abdulhay, M. (2025, May). MORPHOLOGICAL AND CLINICAL INDICATIONS OF COMPLICATIONS OF CARDIOVASCULAR DISEASE ARCUS SENILIS. In International Conference on Multidisciplinary Sciences and Educational Practices (pp. 182-184).

Rosmayanti Siregar et al. Cellulitis as complication of nephrotic syndrome in a pediatric patient. 2018. Vol. 125, № 1. P. 012111.

Se Jin Park, Jae Il Shin. Complications of nephrotic syndrome. // Korean Journal of Pediatrics. 2011. Vol. 54, № 8. P. 322–328.